Practice and Associated Factors of Human Papillomavirus Vaccination Among Primary School Students in Minjar-Shenkora District, North Shoa Zone, Amhara Regional State, Ethiopia, 2020

References

• World Health Organization. Human papillomavirus (HPV), and cervical cancer. Summary report. Available from: https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer. Accessed September 2, 2021.
   Google Scholar
• WeaverBA. Epidemiology and natural history of genital human papillomavirus infection. Int J Osteopath Med. 2006;106(s1):2–8.
   Google Scholar
• Bruni L, Albero G, Serrano B, et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Pakistan. Summary Report 17 June 2019. Available from: http://www.hpvcentre.net/statistics/reports/PAK.pdf. Accessed September 2, 2021.
   Google Scholar
• TotaJE, Chevarie-DavisM, RichardsonLA, DevriesM, FrancoEL. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med. 2011;53(Suppl 1):S12–21. PMID: 21962466. doi:10.1016/j.ypmed.2011.08.01721962466
   PubMed Web of Science ®Google Scholar
• ParkinDM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030–3044. PMID: 16404738. doi:10.1002/ijc.2173116404738
   PubMed Web of Science ®Google Scholar
• CliffordGM, SmithJS, PlummerM, MuñozN, FranceschiS. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003;88(1):63–73. PMID: 12556961; PMCID: PMC2376782. doi:10.1038/sj.bjc.660068812556961
   PubMed Web of Science ®Google Scholar
• BoschFX, de SanjoséS. Chapter 1: human papillomavirus and cervical cancer—burden and assessment of causality. JNCI Monographs. 2003;2003(31):3–13. doi:10.1093/oxfordjournals.jncimonographs.a003479
   Google Scholar
• GarlandSM, StebenM, SingsHL, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized Phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis. 2009;199(6):805–814. PMID: 19199546. doi:10.1086/59707119199546
   PubMed Web of Science ®Google Scholar
• GissmannL, WolnikL, IkenbergH, KoldovskyU, SchnürchHG, Zur HausenH. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci U S A. 1983;80(2):560–563. PMID: 6300854; PMCID: PMC393419. doi:10.1073/pnas.80.2.5606300854
   PubMed Web of Science ®Google Scholar
• Wilson ChialepehN, SathiyasusumanA. Associated risk factors of STIs and multiple sexual relationships among youths in Malawi. PLoS One. 2015;10(8):e0134286. doi:10.1371/journal.pone.013428626248328
   PubMed Web of Science ®Google Scholar
• SongthapA, PitisuttithumP, KaewkungwalJ, FungladdaW, BussaratidV. Knowledge, attitudes, and acceptability of a human papilloma virus vaccine among students, parents and teachers in Thailand. Southeast Asian J Trop Med Public Health. 2012;43(2):340–353. PMID: 23082586.23082586
   PubMed Web of Science ®Google Scholar
• MarkowitzLE, DunneEF, SaraiyaM, et al.; Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014;63(RR–05):1–30. Erratum in: MMWR Recomm Rep. 2014;63(49):1182. PMID: 25167164.
   PubMed Web of Science ®Google Scholar
• SmithJS, LindsayL, HootsB, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121(3):621–632. doi:10.1002/ijc.2252717405118
   PubMed Web of Science ®Google Scholar
• HarperDM, FrancoEL, WheelerCM, et al.; HPV Vaccine Study group. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006;367(9518):1247–1255. PMID: 16631880. doi:10.1016/S0140-6736(06)68439-016631880
   PubMed Web of Science ®Google Scholar
• WrightTC, Van DammeP, SchmittHJ, MeheusA. Chapter 14: HPV vaccine introduction in industrialized countries. Vaccine. 2006;24(Suppl 3):S3/122–31. PMID: 16949999. doi:10.1016/j.vaccine.2006.05.118
   Web of Science ®Google Scholar
• World Economic Outlook (WEO). Tensions from the Two-Speed Recovery: Unemployment, Commodities, and Capital Flows April 2011. Available from: imf.org/en/Publications/WEO/Issues/2016/12/31/Tensions-from-the-Two-Speed-Recovery-Unemployment-Commodities-and-Capital-Flows. Accessed September 2, 2021.
   Google Scholar
• MacKianSA review of health-seeking behaviour: problems and prospects. Manchester: Health Systems Development Programme, University of Manchester; 2003.
   Google Scholar
• KatahoireAR, WaniJA, MurokoraD, MugishaE, LamontagneD. Acceptability of HPV vaccine among young adolescent girls in Uganda: young people’s perspectives count. Int J Child Adolesc Health. 2013;6:211.
   Google Scholar
• BrewerNT, FazekasKI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45(2–3):107–114. PMID: 17628649. doi:10.1016/j.ypmed.2007.05.01317628649
   PubMed Web of Science ®Google Scholar
• ReiterPL, BrewerNT, GottliebSL, McReeAL, SmithJS. Parents’ health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med. 2009;69(3):475–480. PMID: 19540642. doi:10.1016/j.socscimed.2009.05.02419540642
   PubMed Web of Science ®Google Scholar
• GottliebSL, BrewerNT, SternbergMR, et al. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health. 2009;45(5):430–437. PMID: 19837348. doi:10.1016/j.jadohealth.2009.03.02919837348
   PubMed Web of Science ®Google Scholar
• World Health Organization.WHO guidance note: comprehensive cervical cancer prevention and control: a healthier future for girls and women. World Health Organization; 2013. Available from:https://apps.who.int/iris/handle/10665/78128. Accessed 825, 2021.
   Google Scholar
• World Health Organization. WHO Guideline on Health Policy and System Support to Optimize Community Health Worker Programmes. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO.
   Google Scholar
• MakuzaJD, NsanzimanaS, MuhimpunduMA, PaceLE, NtaganiraJ, RiedelDJ. Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda. Pan Afr Med J. 2015;22:26. doi:10.11604/pamj.2015.22.26.711626664527
   PubMedGoogle Scholar
• ICO/IARC Information Centre on HPV and Cancer. Human Papillomavirus and Related Cancers, Fact Sheet 2018. Available from: https://hpvcentre.net/statistics/reports/ETH_FS.pdf. Accessed September 2, 2021.
   Google Scholar
• KisaakyeE, NamakulaJ, KihemboC, KisakyeA, NsubugaP, BabiryeJN. Level and factors associated with uptake of human papillomavirus infection vaccine among female adolescents in Lira District, Uganda. Pan Afr Med J. 2018;31:184. PMID: 31086634; PMCID: PMC6488240. doi:10.11604/pamj.2018.31.184.1480131086634
   PubMed Web of Science ®Google Scholar
• JalaniFF, RaniM, IsahakI, ArisMS, RoslanN. Knowledge, attitude and practice of human papillomavirus (HPV) Vaccination among Secondary School Students in Rural Areas of Negeri Sembilan, Malaysia. Int J Collab Res Intern Med Public Health. 2016;8(6):56.
   Google Scholar
• DubéE, GagnonD, ClémentP, et al.; Canadian Immunization Research Network. Challenges and opportunities of school-based HPV vaccination in Canada. Hum Vaccin Immunother. 2019;15(7–8):1650–1655. PMID: 30633622; PMCID: PMC6746476. doi:10.1080/21645515.2018.156444030633622
   PubMed Web of Science ®Google Scholar
• LeungJTC, LawC. Revisiting knowledge, attitudes and practice (KAP) on human papillomavirus (HPV) vaccination among female university students in Hong Kong. Hum Vaccin Immunother. 2018;14(4):924–30. Informa UK Limited. doi:10.1080/21645515.2017.1415685
   Web of Science ®Google Scholar
• Di GiuseppeG, AbbateR, LiguoriG, AlbanoL, AngelilloIF. Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. Br J Cancer. 2008;99(2):225–229. PMID: 18628763; PMCID: PMC2480983. doi:10.1038/sj.bjc.660445418628763
   PubMed Web of Science ®Google Scholar
• RashwanHH, SaatNZ, Abd MananDN. Knowledge, attitude and practice of Malaysian medical and pharmacy students towards human papillomavirus vaccination. Asian Pac J Cancer Prev. 2012;13(5):2279–2283. PMID: 22901207. doi:10.7314/apjcp.2012.13.5.227922901207
   PubMedGoogle Scholar
• MathurMB, MathurVS, ReichlingDB. Participation in the decision to become vaccinated against human papillomavirus by California high school girls and the predictors of vaccine status. J Pediatr Health Care. 2010;24(1):14–24. PMID: 20122474. doi:10.1016/j.pedhc.2008.11.00420122474
   PubMed Web of Science ®Google Scholar
• KimM, LeeH, KiangP, et al. HPV vaccination and Korean American College Women: cultural factors, knowledge, and attitudes in cervical cancer prevention. J Community Health. 2019;44(4):646–655. doi:10.1007/s10900-019-00634-930863974
   PubMed Web of Science ®Google Scholar
• ChiangVC, WongHT, YeungPC, et al. Attitude, acceptability and knowledge of HPV vaccination among local university students in Hong Kong. Int J Environ Res Public Health. 2016;13(5):486. PMID: 27187424; PMCID: PMC4881111. doi:10.3390/ijerph13050486
   PubMed Web of Science ®Google Scholar